Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
WNK1 (with-no-lysine[K]-1) is a protein kinase of which mutations cause a familial hypertension and hyperkalemia syndrome known as pseudohypoaldosteronism type 2 (PHA2). Kidney-specific (KS) WNK1 is an alternatively spliced form of WNK1 kinase missing most of the kinase domain. KS-WNK1 downregulates the Na(+)-Cl(-) cotransporter NCC by antagonizing the effect of full-length WNK1 when expressed in Xenopus oocytes. The physiological role of KS-WNK1 in the regulation of NCC and potentially other Na(+) transporters in vivo is unknown. Here, we report that mice overexpressing KS-WNK1 in the kidney exhibited renal Na(+) wasting, elevated plasma levels of angiotensin II and aldosterone yet lower blood pressure relative to wild-type littermates. Immunofluorescent staining revealed reduced surface expression of total and phosphorylated NCC and the Na(+)-K(+)-2Cl(-) cotransporter NKCC2 in the distal convoluted tubule and the thick ascending limb of Henle's loop, respectively. Conversely, mice with targeted deletion of exon 4A (the first exon for KS-WNK1) exhibited Na(+) retention, elevated blood pressure on a high-Na(+) diet and increased surface expression of total and phosphorylated NCC and NKCC2 in respective nephron segments. Thus, KS-WNK1 is a negative regulator of NCC and NKCC2 in vivo and plays an important role in the control of Na(+) homeostasis and blood pressure. These results have important implications to the pathogenesis of PHA2 with WNK1 mutations.
Anselmo,
WNK1 and OSR1 regulate the Na+, K+, 2Cl- cotransporter in HeLa cells.
2006, Pubmed
Anselmo,
WNK1 and OSR1 regulate the Na+, K+, 2Cl- cotransporter in HeLa cells.
2006,
Pubmed Delaloy,
Deletion of WNK1 first intron results in misregulation of both isoforms in renal and extrarenal tissues.
2008,
Pubmed Delaloy,
Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform.
2003,
Pubmed Delpire,
SPAK and OSR1: STE20 kinases involved in the regulation of ion homoeostasis and volume control in mammalian cells.
2008,
Pubmed Delpire,
Molecular cloning and chromosome localization of a putative basolateral Na(+)-K(+)-2Cl- cotransporter from mouse inner medullary collecting duct (mIMCD-3) cells.
1994,
Pubmed Gagnon,
On the substrate recognition and negative regulation of SPAK, a kinase modulating Na+-K+-2Cl- cotransport activity.
2010,
Pubmed
,
Xenbase Guo,
Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry.
2006,
Pubmed Haas,
The Na-K-Cl cotransporter of secretory epithelia.
2000,
Pubmed He,
Polarized distribution of key membrane transport proteins in the rat submandibular gland.
1997,
Pubmed He,
Intersectin links WNK kinases to endocytosis of ROMK1.
2007,
Pubmed Kahle,
WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion.
2003,
Pubmed
,
Xenbase Kaplan,
Expression of the mouse Na-K-2Cl cotransporter, mBSC2, in the terminal inner medullary collecting duct, the glomerular and extraglomerular mesangium, and the glomerular afferent arteriole.
1996,
Pubmed Lazrak,
Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms.
2006,
Pubmed Liu,
Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase.
2009,
Pubmed Moriguchi,
WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
2005,
Pubmed Mutig,
Short-term stimulation of the thiazide-sensitive Na+-Cl- cotransporter by vasopressin involves phosphorylation and membrane translocation.
2010,
Pubmed Náray-Fejes-Tóth,
The kidney-specific WNK1 isoform is induced by aldosterone and stimulates epithelial sodium channel-mediated Na+ transport.
2004,
Pubmed Ohta,
Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure.
2009,
Pubmed O'Reilly,
WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain.
2003,
Pubmed O'Reilly,
Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo.
2006,
Pubmed
,
Xenbase Pacheco-Alvarez,
The Na+:Cl- cotransporter is activated and phosphorylated at the amino-terminal domain upon intracellular chloride depletion.
2006,
Pubmed
,
Xenbase Payne,
Primary structure, functional expression, and chromosomal localization of the bumetanide-sensitive Na-K-Cl cotransporter in human colon.
1995,
Pubmed Pedersen,
Vasopressin induces phosphorylation of the thiazide-sensitive sodium chloride cotransporter in the distal convoluted tubule.
2010,
Pubmed Rafiqi,
Role of the WNK-activated SPAK kinase in regulating blood pressure.
2010,
Pubmed Richardson,
Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.
2008,
Pubmed Richardson,
The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway.
2008,
Pubmed Subramanya,
Dominant-negative regulation of WNK1 by its kidney-specific kinase-defective isoform.
2006,
Pubmed
,
Xenbase Veríssimo,
WNK kinases, a novel protein kinase subfamily in multi-cellular organisms.
2001,
Pubmed Vinciguerra,
Aldosterone, but not increased Na+ influx or NF-kappaB activation, increases kidney-specific WNK1 gene expression in renal collecting duct cells.
2009,
Pubmed Vitari,
The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
2005,
Pubmed Wilson,
Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4.
2003,
Pubmed
,
Xenbase Wilson,
Human hypertension caused by mutations in WNK kinases.
2001,
Pubmed Xu,
WNK1 activates SGK1 to regulate the epithelial sodium channel.
2005,
Pubmed Xu,
WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II.
2000,
Pubmed Yamauchi,
Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins.
2004,
Pubmed
,
Xenbase Yang,
Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model.
2007,
Pubmed Yang,
WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
2003,
Pubmed
,
Xenbase Yang,
Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport.
2005,
Pubmed
